Alector Inc (ALEC)

22.16 +2.33  +11.75% NASDAQ Dec 7, 14:40 USD
View Full Chart
Price Chart
View All ALEC News

News

View All Events

Events

Date Type Description
02/25/2022 Earnings Results Q4 2021 Earnings Results
11/04/2021 Earnings Results Q3 2021 Earnings Results
08/03/2021 Earnings Results Q2 2021 Earnings Results
06/17/2021 11:00 EST AGM 2021 Annual General Meeting
05/05/2021 Earnings Results Q1 2021 Earnings Results
02/25/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101.
  • URL: https://www.alector.com
  • Investor Relations URL: https://investors.alector.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 25, 2022
  • Last Earnings Release: Nov. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
FWYARX FT Biotechnology 55 RE 3.42%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.